[Pathologic and therapeutic similarities between arteriosclerosis and lithiasic cholecystitis].
D000081:Acetamides / Q000627:therapeutic use; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000818:Animals; D001161:Arteriosclerosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D001241:Aspirin / Q000627:therapeutic use; D002764:Cholecystitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D002769:Cholelithiasis / Q000150:complications* / Q000175:diagnosis; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008055:Lipids / Q000097:blood; D051379:Mice; D013974:Thyroxine / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000081:Acetamides; D000636:Aminosalicylic Acids; D008055:Lipids; D002792:Cholestyramine Resin; D014810:Vitamin E; D002784:Cholesterol; D002994:Clofibrate; D013974:Thyroxine; D001241:Aspirin
Similitudes pathologiques et thérapeutiques entre l'athérosclérose et la cholécystite lithiasique.